UBS Group’s Albany Molecular Research Inc AMRI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-2,100
| Closed | -$46K | – | 7142 |
|
|
2017
Q2 | $46K | Buy |
2,100
+1,926
| +1,107% | +$42.2K | ﹤0.01% | 4808 |
|
|
2017
Q1 | $2K | Sell |
174
-621
| -78% | -$7.14K | ﹤0.01% | 6428 |
|
|
2016
Q4 | $14K | Buy |
795
+24
| +3% | +$423 | ﹤0.01% | 5790 |
|
|
2016
Q3 | $13K | Sell |
771
-815
| -51% | -$13.7K | ﹤0.01% | 5720 |
|
|
2016
Q2 | $22K | Sell |
1,586
-289
| -15% | -$4.01K | ﹤0.01% | 5371 |
|
|
2016
Q1 | $28K | Sell |
1,875
-1,203
| -39% | -$18K | ﹤0.01% | 5141 |
|
|
2015
Q4 | $61K | Buy |
3,078
+2,011
| +188% | +$39.9K | ﹤0.01% | 4606 |
|
|
2015
Q3 | $19K | Sell |
1,067
-906
| -46% | -$16.1K | ﹤0.01% | 5510 |
|
|
2015
Q2 | $40K | Buy |
1,973
+1,173
| +147% | +$23.8K | ﹤0.01% | 4940 |
|
|
2015
Q1 | $14K | Buy |
800
+394
| +97% | +$6.9K | ﹤0.01% | 5681 |
|
|
2014
Q4 | $7K | Buy |
+406
| New | +$7K | ﹤0.01% | 6215 |
|